Celanese Lowers 2024 Profit Forecast Due to Sluggish Demand and Production Issues
On Thursday, Celanese Corporation, a prominent player in the specialty chemicals industry, announced a significant reduction in its 2024 earnings forecast, which led to a sharp 5.4% decline in its stock price following the market close. This downward revision reflects ongoing difficulties the company is facing due to a combination of weak demand in critical sectors and operational challenges.
Celanese’s updated guidance for the year now projects earnings per share (EPS) to be between $10.25 and $10.75. This is a substantial decrease from the previous forecast range of $11 to $12 per share. The revised EPS range also falls short of Wall Street’s consensus estimate of $11.11 per share, as reported by LSEG data. The adjustment highlights the significant pressures the company is encountering, which have impacted its financial outlook.
A key factor contributing to Celanese’s revised forecast is the weakening of global manufacturing activity. Economic data from the past few months indicate a contraction in manufacturing in China, one of the world’s largest economies, as well as a decline in the eurozone. The weakening manufacturing sector has led to a drop in demand for raw materials, which is critical to Celanese’s operations. The company’s reliance on stable manufacturing activity for its raw material needs has been severely tested by these recent economic trends.
Adding to the company’s troubles, Celanese declared force majeure for its acetic acid and vinyl acetate monomer products sold in the Western Hemisphere in June. This declaration, a formal notification that it cannot meet contractual obligations due to unforeseen circumstances, was prompted by severe shortages in raw materials and significant operational issues. The Clear Lake production facility, which is crucial for Celanese’s low-cost production, experienced the highest level of losses in over 15 years. This facility faced 66 days of curtailed feedstock supplies, exacerbating the company’s production and supply chain difficulties.
In its second-quarter earnings report, Celanese also revealed that its adjusted profit was $2.38 per share, falling short of the analyst expectations of $2.71 per share. This miss reflects the broader challenges faced by the company in maintaining profitability amid adverse market conditions. Additionally, the company reported a 5% sequential decline in net sales within its Acetyl Chain segment, driven by decreases in both prices and volumes. This segment is a significant part of Celanese’s business, and the reduction in sales underscores the ongoing difficulties in the market.
Celanese’s CEO, Lori Ryerkerk, expressed a cautious outlook for the remainder of the year, stating, “We are seeing stability but not recovery to normalized levels.” This comment reflects the company’s expectation of continued challenges in the macroeconomic environment, suggesting that while conditions may stabilize, a full recovery to pre-crisis levels is not yet in sight.
Overall, Celanese’s revised earnings forecast and disappointing second-quarter performance highlight the substantial challenges facing the company and the broader specialty chemicals sector. The confluence of weak global manufacturing, operational disruptions, and fluctuating raw material availability has created a challenging environment for the company. As it navigates these issues, Celanese’s performance and stock price will likely continue to be closely monitored by investors and analysts, with ongoing scrutiny of how it manages these challenges and adapts to the evolving market conditions.
